PMA device
Vns Therapy System
LivaNova USA, Inc. · Stimulator, Autonomic Nerve, Implanted (Depression) (MUZ, Class III) · First FDA decision Jul 15, 2005, newest Feb 12, 2016DepressionEpilepsy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
124
Naming "Vns Therapy"
MAUDE reports
32
Brand "Vns Therapy", since 2015
PubMed studies
429
Mentioning "Vns Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vns Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- VNS THERAPY SYSTEMPMA supplement
P970003-S170 · Decided Feb 12, 2016 · 655 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, autonomic nerve, implanted (depression) (MUZ) · Neurology & Neurosurgery
- VNS THERAPY SYSTEMPMA supplement
P970003-S174 · Decided Jun 4, 2015 · 199 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, autonomic nerve, implanted (depression) (MUZ) · Neurology & Neurosurgery
- VNS THERAPY SYSTEMPMA supplement
P970003-S166 · Decided May 9, 2014 · 189 days after receipt · Normal 180 Day Track
Device type: Stimulator, autonomic nerve, implanted (depression) (MUZ) · Neurology & Neurosurgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vns Therapy", any status and sponsor, newest update first.
- Closed-Loop Vagus Nerve Stimulation (CLV) for Recovery of Gait After Spinal Cord Injury (SCI)Not yet recruiting
The University of Texas at DallasAcademic, hospital or other
NCT07689227 · 20 participants (planned) · Start Dec 30, 2026 · Primary completion Dec 2028
Device: CLV; Sham · For: Spinal Cord Injury (SCI); Gait; Reduced Physical Activity and 4 more
Sites: Boston, Massachusetts; Dallas, Texas; Richardson, Texas · 4 sites in all
- Biomarkers of Paired VNSRecruiting
MGH Institute of Health ProfessionsAcademic, hospital or other
NCT07922200 · 50 participants (planned) · Start Mar 26, 2026 · Primary completion Oct 1, 2029
Device: Vagus Nerve Stimulator · For: Stroke, Ischemic
Sites: Boston, Massachusetts
- Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory EpilepsyRecruiting
Cliniques universitaires Saint-Luc- Université Catholique de LouvainAcademic, hospital or other
NCT07909486 · 20 participants (planned) · Start Feb 28, 2022 · Primary completion Sep 1, 2025
Device: Vagus nerve stimulation · For: Refractory Epilepsy
Sites: Brussels, Belgium
121 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vns Therapy", and for the whole product code for context.
This brand
32 reports: 17 malfunction, 13 injury, 2 death
Whole product code MUZ
952 reports: 394 malfunction, 514 injury, 44 death
Newest reports for this brand
MW6003561 · Received Oct 7, 2026 · Event dated Apr 14, 2025
Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Device problem as coded: Impedance Problem; Material Protrusion/Extrusion; Migration
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
25300226 · Received May 27, 2026 · Event dated May 1, 2026
Device type: Stimulator, Autonomic Nerve, Implanted (Depression) (MUZ)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
MW5178973 · Received Nov 18, 2025 · Event dated Nov 13, 2025
Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Device problem as coded: Therapeutic or Diagnostic Output Failure
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1067-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
Z-1068-2025 · Started Jan 3, 2025 · Posted by FDA Jan 30, 2025
Reason given: Their is a potential that implanted pulse generators may stop delivering therapy due to an internal component issue.
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
- SenTiva, REF: 1000; SenTiva Duo, REF: 1000-D; Generators Part of the VNS Therapy System. Used for Vagus Nerve Stimulation (VNS).Open, Classified
Z-1072-2025 · Started Dec 12, 2024 · Posted by FDA Jan 31, 2025
Reason given: Vagus nerve stimulator generators may stop delivering stimulation due to an internal, mechanically activated component that may become stuck in a closed position, which may result in patients returning to baseline seizure frequency or depressive symptoms and in the longer term, patients may be required to undergo...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Autonomic Nerve, Implanted For Epilepsy (LYJ)
27 more recall records with a free account
Published research
The most relevant PubMed records for "Vns Therapy"[tiab]. The summary above synthesizes these.
- VNS therapy.
Murphy W · Can J Neurol Sci · 2008Comment, Editorial
- How to fail with paired VNS therapy.
Hays SA, Rennaker RL, Kilgard MP · Brain Stimul · 2023Review, Research Support, N.I.H., Extramural
- Vagus nerve stimulation (VNS) therapy update.
Wheless JW, Gienapp AJ, Ryvlin P · Epilepsy Behav · 2018Review
- Vagus nerve stimulation therapy for treatment-resistant PTSD.
Powers MB, Hays SA, Rosenfield D, et al. · Brain Stimul · 2025Clinical Trial
- Rapid titration of VNS therapy reduces time-to-response in epilepsy.
Tzadok M, Verner R, Kann L, et al. · Epilepsy Behav · 2022Research Support, Non-U.S. Gov't
- Vagus nerve stimulation: current concepts.
Mapstone TB · Neurosurg Focus · 2008Review
- Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry.
Sen A, Verner R, Valeriano JP, et al. · BMJ Neurol Open · 2021
- VNS parameters for clinical response in Epilepsy.
Fahoum F, Boffini M, Kann L, et al. · Brain Stimul · 2022Research Support, Non-U.S. Gov't
- Feasibility study of microburst VNS therapy in drug-resistant focal and generalized epilepsy.
Drees C, Afra P, Verner R, et al. · Brain Stimul · 2024Research Support, Non-U.S. Gov't
- Vagus Nerve Stimulation in Intractable Epilepsy.
Boluk C, Ozkara C, Isler C, et al. · Turk Neurosurg · 2022
- Vagal Nerve Stimulation: The Effect on the Brain Oscillatory Field Potential.
Broncel A, Bocian R, Konopacki J · Neuroscience · 2022Research Support, Non-U.S. Gov't, Review
- Corpus callosotomy in children.
Wong TT, Kwan SY, Chang KP, et al. · Childs Nerv Syst · 2006Clinical Trial, Comparative Study
Other devices of this type
Also filed under product code MUZ.
- Aspiresr Generator -Model 106LivaNova USA, Inc. · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.